Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

TRIM Inhibitors

TRIM inhibitors are a class of chemical compounds designed to target and inhibit the function of the TRIM (Tripartite Motif) family of proteins, which are involved in a variety of cellular processes, including protein ubiquitination, intracellular signaling, and the regulation of gene expression. TRIM proteins are characterized by the presence of a tripartite motif, which includes a RING domain, a B-box, and a coiled-coil region. These proteins play essential roles in regulating the stability and activity of other proteins by tagging them with ubiquitin, marking them for degradation via the proteasome, or modulating their activity in different signaling pathways. By inhibiting TRIM proteins, these compounds can disrupt their ability to regulate ubiquitination and the associated cellular processes, leading to changes in protein homeostasis, signal transduction, and gene regulation.

The development of TRIM inhibitors focuses on identifying small molecules that can specifically bind to key functional domains of TRIM proteins, particularly the RING domain, which is responsible for their E3 ubiquitin ligase activity. These inhibitors work by blocking the ability of TRIM proteins to catalyze the transfer of ubiquitin to target proteins, thereby affecting processes such as protein degradation, signal transduction, and cellular stress responses. Structural studies of various TRIM proteins have provided detailed insights into the molecular architecture of the tripartite motif, guiding the design of inhibitors with high specificity and selectivity. By studying TRIM inhibitors, researchers can gain a deeper understanding of how TRIM proteins regulate critical cellular functions, offering insights into the molecular mechanisms that govern protein turnover, intracellular signaling, and the dynamic control of gene expression. These inhibitors are valuable tools for investigating the diverse roles of the TRIM family in maintaining cellular homeostasis and responding to environmental or intracellular stress.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

JQ1 targets BET bromodomains, which may indirectly affect TRIM protein-related pathways by altering the transcription of key genes.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG132 is a proteasome inhibitor which can increase the cellular concentration of TRIM proteins, potentially affecting their activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 inhibits PI3K, potentially modulating pathways that could interact with TRIM protein function.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAP kinase inhibitor which may influence TRIM protein-related signaling.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 inhibits JNK and can modulate stress response pathways that TRIM proteins may be part of.

BAY 11-7085

196309-76-9sc-202490
sc-202490A
10 mg
50 mg
$124.00
$526.00
55
(2)

This molecule inhibits the degradation of IκBα, affecting NF-κB pathway activation where TRIM proteins may be involved.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, which may impact TRIM protein-related pathways by altering cell growth and metabolism.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib is another proteasome inhibitor which could affect the stability and function of TRIM proteins.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Dasatinib is a broad-spectrum tyrosine kinase inhibitor that could intersect with signaling pathways involving TRIM proteins.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$111.00
$357.00
8
(0)

Thalidomide affects protein degradation, potentially impacting the function of TRIM proteins by modulating related ubiquitin ligase activity.